These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10498219)

  • 1. The design of (-)-(S)-2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl) pyridine-5-carboxylate: a cardioselective positive inotropic derivative of Bay K 8644.
    Shan R; Knaus EE
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2613-4. PubMed ID: 10498219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses, calcium channel agonist-antagonist modulation activities, nitric oxide release, and voltage-clamp studies of 2-nitrooxyethyl 1,4-dihydro- 2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)pyridine-5-carboxylate enantiomers.
    Shan R; Howlett SE; Knaus EE
    J Med Chem; 2002 Feb; 45(4):955-61. PubMed ID: 11831908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
    Shan R; Velazquez C; Knaus EE
    J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
    Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
    J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photosensitization of oesophageal smooth muscle by 3-NO2-1, 4-dihydropyridines: evidence for two cyclic GMP-dependent effector pathways.
    Martin-Caraballo M; Triggle CR; Bieger D
    Br J Pharmacol; 1995 Dec; 116(8):3293-301. PubMed ID: 8719810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and synthesis of methyl 2,5-dimethyl-4-[2- (phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylate (FPL 64176) and analogues: the first examples of a new class of calcium channel activator.
    Baxter AJ; Dixon J; Ince F; Manners CN; Teague SJ
    J Med Chem; 1993 Sep; 36(19):2739-44. PubMed ID: 7692047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A search for calcium-channel activators in the verapamil series.
    Romanelli MN; Gualtieri F; Mannhold R; Chiarini A
    Farmaco; 1989 May; 44(5):449-64. PubMed ID: 2476997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of Ca release from mammalian ventricular sarcoplasmic reticulum by the calcium channel agonist Bay K 8644.
    Hryshko LV; Bose D
    Br J Pharmacol; 1988 Jun; 94(2):291-2. PubMed ID: 2456113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dihydropyridine-type calcium agonists on hemodynamics and myocardial ischemia in isolated rabbit hearts.
    Rump AF; Rösen R; Sigmund B; Fuchs J; Ratke R; Klaus W
    Arzneimittelforschung; 1993 Oct; 43(10):1056-9. PubMed ID: 7505584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of myocardial economy and efficiency in mammalian failing and non-failing myocardium by calcium channel activation and beta-adrenergic stimulation.
    Ruf T; Hebisch S; Gross R; Alpert N; Just H; Holubarsch C
    Cardiovasc Res; 1996 Dec; 32(6):1047-55. PubMed ID: 9015407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-py rid ine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells.
    Sen N; Wu AM; Spitzer AR; Chander A
    Biochem Pharmacol; 1997 May; 53(9):1307-13. PubMed ID: 9214691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the negative inotropic effects of 17 beta-oestradiol in human isolated myocardial tissues.
    Sitzler G; Lenz O; Kilter H; La Rosee K; Böhm M
    Br J Pharmacol; 1996 Sep; 119(1):43-8. PubMed ID: 8872355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-induced relaxation of smooth muscle after treatment with BAY K 8644 is related to release of nitric oxide.
    Golenhofen K; Finger K; Förster B; Mandrek K; Noack T
    Prog Clin Biol Res; 1990; 327():595-604. PubMed ID: 1690899
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
    Schramm M; Thomas G; Towart R; Franckowiak G
    Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of the dihydropyridine-type calcium-agonists (-)-S-Bay K 8644, (+/-)-Bay-W 5035 and (+/-)-Bay-T 5006 on human platelet aggregability.
    Rump AF; Boller M; Berkels R; Rösen R; Fricke U; Klaus W
    Gen Pharmacol; 1994 May; 25(3):447-50. PubMed ID: 7523235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+ buffering action of sarcoplasmic reticulum on Bay k 8644-induced Ca2+ influx in rat femoral arterial smooth muscle.
    Asano M; Nomura Y
    Eur J Pharmacol; 1999 Jan; 366(1):61-71. PubMed ID: 10064153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.